Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Saudi Arabia Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors ...
May 2019
535 pages
South Africa Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors ...
May 2019
535 pages
South Korea Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors ...
May 2019
535 pages
United Arab Emirates Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, ...
May 2019
535 pages
U.K. Hospital Infectious Disease Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,450.00
... , 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory ...
May 2019
886 pages
U.S. Hospital Infectious Disease Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 6,800.00
... , 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory ...
May 2019
997 pages
U.S. Hospital Microbiology Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 6,800.00
... , 87 tables, and presents a comprehensive analysis of the US hospital microbiology testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory ...
May 2019
997 pages
